WordPress

Briefly unavailable for scheduled maintenance.
Check back in a some hours.
Cancer – Melatonin Facts

Cancer

Cancer

There have been studies on melatonin as an effective anti-cancer hormone for several decades. It has been demonstrated to alleviate the symptoms of the early-stage, progression and metastasis phases and have a positive impact on the course of the disease. The anti-oxidative and immunoregulatory properties of melatonin and its effect on tumour-specific cell division are responsible for this.

Melatonin inhibits tumour growth

As a “natural killer”, melatonin plays a key role in the uncontrolled growth of cells. Specifically, it reduces the cell division rate, for example by reducing telomerase activity, which results in the programmed cell death of the tumour cells. The researchers also found that melatonin possesses the ability to affect angiogenesis, which is the growth and formation of blood vessels that supply the tumour with oxygen and nutrients, thus facilitating its growth.

An effective accompaniment to therapy

The supportive effect of melatonin during conventional cancer treatments is also proven – for instance, the often toxic consequences of radiotherapy or chemotherapy can be mitigated using melatonin while also enhancing its effectiveness – according to the results of many studies. Studies have also shown that melatonin can affect the treatment resistance of some tumours, making them more susceptible to chemotherapy.

Scroll to Top